Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue



Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report

 

Key Questions Answered in this Report?

  • What are the historical, current and future trends in the generic market?
  • What are the historical, current and future trends in the generic oncology market?
  • What is the competitive structure of the generic market and who are the key players?
  • What is the competitive structure of the generic oncology market and who are the key players?
  • What are the key success factors for generic oncology drug manufacturers?
  • How are generic oncology drugs manufactured?
  • What are the raw material requirements and their cost for manufacturing generic oncology drugs?
  • What are the land and construction requirements and their cost for manufacturing generic oncology drugs?
  • What are the machinery requirements and their cost for manufacturing generic oncology drugs?
  • What are the packaging requirements and their cost for manufacturing generic oncology drugs?
  • What are the utility requirements and their cost for manufacturing generic oncology drugs?
  • What are the manpower requirements and their cost for manufacturing generic oncology drugs?
  • What is the total capital investment required for setting up a generic oncology drug manufacturing plant
  • What are the operational costs for setting up a generic oncology drug manufacturing plant?
  • How much income will the generic oncology drug manufacturing plant generate?
  • What will be the profitability of the generic oncology drug manufacturing plant?
  • What will be the NPV of the generic oncology drug manufacturing plant?
  • What will be the payback period of the generic oncology drug manufacturing plant?

1 Research Methodology
2 Report Summary
3 Introduction
4 Global Generic Drug Market

    4.1 Classification of Generic Drugs
    4.2 Market Trends
        4.2.1 Current and Historical Market Trends
        4.2.2 Market Breakup by Region
        4.2.3 Major Players in the Generic Drug Industry
        4.2.4 Market Forecast
    4.3 Value Chain Analysis of Generic Drugs
    4.4 Key Success Factors Driving the Generic Drug Industry
    4.6 Regulations in the Generic Drug Industry
5 Global Cancer Generics Market
    5.1 Global Cancer Statistics
    5.2 Current and Historical Market Trends
    5.3 Top Cancer Drugs
    5.4 Top Players in the Cancer Generics Market
    5.5 Market Forecast
6 Manufacturing Process
    6.1 Detailed Process Flow (Tablet)
    6.2 Detailed Process Flow (Injectables)
    6.3 Cancer Generic Manufacturing Plant: Raw Material Requirements
        6.3.1 Cancer Generic Drug (Tablet)
        6.3.2 Cancer Generic Drug (Injectables)
7 Project Details, Requirements and Costs Involved
    7.1 Land, Location and Site Development
    7.2 Plant Machinery
    7.3 Machinery Pictures
    7.4 Raw Materials
    7.5 Packaging
    7.6 Utilities
    7.7 Manpower
    7.8 Other Capital Investments
8 Cancer Generic Drug Manufacturing Plant: Project Economics
    8.1 Capital Cost of the Project
    8.2 Loans and Financial Assistance
    8.3 Techno-Economic Parameters
    8.4 Product Pricing
    8.5 Income Projections
    8.6 Expenditure Projections
    8.7 Financial Analysis

 

 

List of Figures

Figure 1 1: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 4 1: Global: Generics Market: Sales Value (in US$ Billion), 2011-2015
Figure 4 2: Global: Generics Market: Breakup by Country (in %), 2015
Figure 4 3: Global: Generics Market: Sales Value (in US$ Billion), 2016-2021
Figure 4 4: Global: Generics Market: Value Chain
Figure 5 1: Global: Cancer Incidence: 2008-2015
Figure 5 2: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 5 3: Global: Cancer Generics Market: Sales Value (in US$ Billion), 2008-2015
Figure 5 4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 6 1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow
Figure 6 2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow
Figure 6 3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks
Figure 6 4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks
Figure 7 1: Cancer Generic Manufacturing Plant: Primary Packaging
Figure 7 2: Cancer Generic Manufacturing Plant: Secondary Packaging
Figure 7 3: Cancer Generic Manufacturing Plant: Tertiary Packaging
Figure 8 1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 8 2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)

 

 

List of Tables

Table 4 1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2015
Table 7 1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 7 2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 7 3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)
Table 7 4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)
Table 7 5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 7 6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 8 1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)
Table 8 2: Details of Financial Assistance Offered by Financial Institutions
Table 8 3: Cancer Generic Manufacturing Plant: Loan Installments
Table 8 4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters
Table 8 5: Cancer Generic Manufacturing Plant: Income Projections (in US$)
Table 8 6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)
Table 8 7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 8 8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2016-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2016-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2016-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2016-2021)

The new report from IMARC group entitled ‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2008-2021)’ maps out a comprehensive analysis o...


Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand...


Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Japan Generic Drug Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to understand th...